# SOLX Titanium Sapphire Laser for Trabeculoplasty

> **NCT00145535** · PHASE3 · COMPLETED · sponsor: **SOLX, Inc.** · enrollment: 120 (estimated)

## Conditions studied

- Glaucoma
- Glaucoma, Open Angle

## Interventions

- **DEVICE:** SOLX Titanium Sapphire Laser (TiSaLT)
- **DEVICE:** Argon Laser Trabeculoplasty (ALT)

## Key facts

- **NCT ID:** NCT00145535
- **Lead sponsor:** SOLX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2010-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145535, "SOLX Titanium Sapphire Laser for Trabeculoplasty". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00145535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*